BIIB - Eli Lilly Alzheimer's therapy set for June FDA AdCom meeting
2024-05-07 09:38:29 ET
More on Eli Lilly
- Eli Lilly: Great Time To Divest Before It Potentially Crashes
- Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
- Eli Lilly: Don't Overpay For Miracle Drugs
- Pharma R&D productivity seen improving for the first time in years - Deloitte
- Palatin gets FDA OK to test weight loss therapy with Eli Lilly’s tirzepatide